Search Results

Safety and Performance Outcomes Published for Biotronik's Biovalve TAVR Device

October 18, 2019—In Journal of the American College of Cardiology (JACC): Cardiovascular Interventions, Ulrich Schäfer, MD, et al published findings from the first-in-human BIOVALVE I and II studies of the safety and performance of the newly introduced Biovalve transfemoral self-expanding supra-annular transcatheter heart valve (Biotronik).

Medtronic Gains CE Mark Approval for 31-mm CoreValve System

August 18, 2011—Medtronic, Inc. (Minneapolis, MN) announced it has received CE Mark approval for its 31-mm CoreValve transcatheter aortic valve system for the treatment of patients with larger valve openings (up to 29 mm).

BIOVALVE Trial Evaluates Biotronik's Resheathable TAVR System

May 12, 2015—Biotronik announced the completion of the BIOVALVE first-in-human trial for its new resheathable transcatheter aortic valve replacement (TAVR) device.

Neovasc Reports on Tiara Clinical Investigation Program

September 12, 2017—Neovasc Inc. announced an update on the study of the company's Tiara valve, a self-expanding mitral bioprosthesis for transcatheter implantation in patients with mitral regurgitation (MR).